TriPollar34
|
Non-RCT |
Human face |
11 |
6 treatments |
Week 4 and 12 |
Skin fine lines, firmness, and brightness were significantly improved |
No adverse reactions |
Not described |
YA—MAN35
|
RCT |
Human face |
33 |
5 times per week for the first 8 weeks |
Week 2,4,8 and 12 |
In the severity of wrinkles (crow’s feet, interlines) and facial sagging |
No adverse reactions |
Not described |
3 times per week for the next 4 weeks |
Silk ‘n36
|
Non-RCT |
Human face |
30 |
2 days once, a total of 21 times |
Week 4 and 8 |
Fitzpatrick The average reduction of the blind assessment score was 1.49 points |
Transient erythema and oedema |
Not described |